Adolfo Ramirez-Zamora, MD
Dr. Adolfo Ramirez Zamora is currently an Associate Professor of Neurology and director of clinical trials at the University of Florida, Center for Movement Disorders and Neurorestoration which is part of the Center for Translational Research in Neurodegenerative Diseases and the McKnight Brain Institute. Dr. Ramirez practiced neurology over the past 5 years at the Parkinson’s Disease and Movement Disorders Center at Albany Medical Center where he served as an Associated Professor of Neurology and the Philly E. Dake Chair in Movement Disorders. Dr. Ramirez completed a surgical internship at Mercy hospital of Philadelphia along with a medicine internship At Bassett Healthcare Hospital in Cooperstown, NY. He then went on to complete his neurology residency at Loyola University Chicago followed by fellowship training in movement disorders at the University of California San Francisco. Dr. Ramirez’s unique areas of expertise encompass management of the entire spectrum of movement disorders, cerebellar ataxias and the use of botulinum toxin injections and Deep Brain Stimulation (DBS) for the treatment of movement disorders.
Dr. Ramirez has a strong interest and experience in conducting clinical trials in Neurology. His clinical focus comprises evaluation of experimental therapeutics in neurology with interested in developing newer treatments in movement disorders.
Dr. Ramierz’s research interests include investigating new DBS surgical and programming techniques in movement disorders, understanding the neurophysiological brain changes observed in these conditions and the use of neuromodulation for the treatment of uncommon neurological diseases.
Professional Society Affiliations
Universidad Autónoma de Guadalajara, Guadalajara, Mexico, 2002
Rotary Internship, Instituto Nacional de las Ciencias Médicas y la Nutrición (National Institute of Medical Sciences and Nutrition), Mexico City, Mexico, 2001
Preliminary Surgery Residency, Mercy Catholic Medical Center, Philadelphia, PA, 2005
Internal Medicine Residency, Bassett Healthcare, Cooperstown, NY, 2006
Neurology Residency, Loyola University, Chicago, IL, 2009
Movement Disorders Fellowship, University of California, San Francisco, 2010
Awards and Recognitions
NINDS Clinical Trials Methodology Course award recipient. NINDS (2015). Selected for participation in this program to develop expertise in clinical trials. Title of the project: “Globus Pallidus Interna Deep Brain Stimulation for treatment of pain and non-motor symptoms in Parkinson’s disease.
Diversity Leadership Program Award recipient. American Academy of Neurology (2015). Recipient of the first diversity leadership class created by the Academy of Neurology to recognize and foster new leaders in the field.
Richard Tyler Fellowship Award recipient. American Academy of Neurology (2015).
Phyllis E. Dake Endowed Chair in Movement Disorders. First Incumbent of the Phyllis E. Dake Endowed Chair in Movement Disorders. Albany Medical Center, Neurosciences Institute (2014).
Dentinger Award. Albany Medical Center. Neurology department award for dedication and excellence in resident’s education (2013).
Ramirez-Zamora A, Gee L. In Reply to: “Hyperhidrosis caused by deep brain stimulation in the posterior subthalamic area” by Patric Blomstedt, MD, PhD. J Neurol Sci. 2017 Sept 15; 380:280.
Eijkholt M, Cabrera LY, Ramirez-Zamora A, Pilitsis JG. Shaking Up the Debate: Ensuring the Ethical Use of DBS Intervention Criteria for Mid-Stage Parkinson’s Patients. Neuromodulation. 2017 Jul; 20(5):411-416.
Chockalingam A, Belasen A, Chen N, Ramirez-Zamora A, Youn Y, Feustel P, Wilock ME, Shin DS, Pilitsis JG. Effect of Eye Opening on Single-Unit Activity and Local Field Potentials in the Subthalamic Nucleus. Neuromodulation. 2017 Jul; 20(5):471-477.
Ramirez-Zamora A, Okun MS. Considering Spastic Paraplegia Type 7 and Adult-Onset Alexander Disease. JAMA Neurol. 2017 Jul 1;74(7):868-869.
O’Connor KA, Mahoney E, Ramirez-Zamora A, Molho ES, Pilitsis JG, Shin DS. Effect of diazepam and yohimbine and neuronal activity in ham and hemiparkinsonian rats. Neuroscience. 2017 May 20;351:71-83.